SCHEMBL23309714

SCHEMBL23309714

CC(C)c1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.51
▸ MAOA P21397 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ TP53 P04637 6/20 0.45
▸ THRB P10828 1/20 0.45
▸ SMN1; SMN2 Q16637 6/20 0.45
▸ NPC1 O15118 6/20 0.45
▸ RAB9A P51151 6/20 0.45
▸ LMNA P02545 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ PLG P00747 2/20 0.44
▸ KLK1 P06870 2/20 0.44
▸ KLK6 Q92876 2/20 0.44
▸ NR3C1 P04150 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309730 0.89 KMT2A (0.47) MAOAMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL23309501 0.86 FADS1 (0.56) SMN1; SMN2
SCHEMBL23309621 0.85 RAB9A (0.50) POLBMAOAMAOBTP53SMN1; SMN2
SCHEMBL23309708 0.85 RAB9A (0.52) POLBSMN1; SMN2NPC1RAB9ALMNA
SCHEMBL23309645 0.84 ALDH1A1 (0.51) TP53SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL23309490 0.81 GAA (0.51) POLBMAOAMAOBTP53SMN1; SMN2
SCHEMBL23309617 0.81 NPC1 (0.54) POLBMAOBTP53SMN1; SMN2NPC1
SCHEMBL23309514 0.81 TRPV1 (0.50) SMN1; SMN2NPC1RAB9AMAPTPLG
SCHEMBL23309739 0.80 NPC1 (0.56) POLBTP53SMN1; SMN2NPC1RAB9A
SCHEMBL23309555 0.80 HTT (0.55) NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL POLB 1411/4885MAOA 1498/4885MAOB 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback